Home/Regentis Biomaterials/Dr. Dror Seliktar
DD

Dr. Dror Seliktar

Co-founder and Scientific Leader (likely former CSO)

Regentis Biomaterials

Regentis Biomaterials Pipeline

DrugIndicationPhase
GelrinCFocal cartilage defects of the knee (osteochondral lesions)Phase 2
GelrinS / Platform DerivativesWound Healing (e.g., Diabetic Foot Ulcers)Pre-clinical